D.Western Therapeutics Institute (6DW) Financial Statements
D.Western Therapeutics Institute Financial Overview
D.Western Therapeutics Institute's market cap is currently $19.28M. The company's EPS TTM is $-12.89; its P/E ratio is -4.96; D.Western Therapeutics Institute has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 387.62M | $ 471.58M | $ 428.36M | $ 448.10M | $ 414.42M |
| Gross Profit | $ 301.24M | $ 424.74M | $ 391.70M | $ 420.53M | $ 394.32M |
| Operating Income | $ -619.87M | $ -1.21B | $ -798.56M | $ -305.91M | $ -171.65M |
| EBITDA | $ -572.35M | $ -1.23B | $ -775.59M | $ -390.75M | $ -110.03M |
| Net Income | $ -632.09M | $ -1.29B | $ -812.41M | $ -429.69M | $ -149.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.71B | $ 1.13B | $ 1.87B | $ 2.33B | $ 1.93B |
| Total Assets | $ 2.17B | $ 1.67B | $ 2.37B | $ 2.96B | $ 2.46B |
| Total Debt | $ 605.18M | $ 797.98M | $ 885.12M | $ 967.69M | $ 340.00M |
| Net Debt | $ -1.10B | $ -328.06M | $ -982.14M | $ -1.37B | $ -1.59B |
| Total Liabilities | $ 734.01M | $ 935.57M | $ 1.09B | $ 1.08B | $ 427.72M |
| Stockholders' Equity | $ 1.44B | $ 733.87M | $ 1.28B | $ 1.86B | $ 2.01B |
| Cash Flow | |||||
| Free Cash Flow | $ -496.54M | $ -1.31B | $ -601.76M | $ -364.58M | $ -179.21M |
| Operating Cash Flow | $ -493.79M | $ -1.30B | $ -586.82M | $ -354.77M | $ -176.31M |
| Investing Cash Flow | $ -2.45M | $ -10.01M | $ -15.25M | $ -139.89M | $ -111.15M |
| Financing Cash Flow | $ 1.08B | $ 567.63M | $ 134.47M | $ 867.30M | $ -104.46M |
Currency in JPY
